Signet healthcare and bionpharma sell corerx, a leading contract development and manufacturer

New york, jan. 19, 2021 (globe newswire) -- signet healthcare partners and bionpharma inc today announced the sale of corerx, a global contract development and manufacturing organization ("cdmo"). following the sale to private equity firm novaquest private equity, signet healthcare partners will retain a meaningful equity stake in corerx. the terms of the transaction are not disclosed.
SIG Ratings Summary
SIG Quant Ranking